EGFL6 Antikörper (EGF-Like-Domain, Multiple 6) (Cy5)

Details for Product anti-EGFL6 Antibody No. ABIN1704647
Antigen
  • MAEG
  • W80
  • Maeg
  • EGF like domain multiple 6
  • EGF-like-domain, multiple 6
  • EGF-like-domain, multiple 6 S homeolog
  • epidermal growth factor-like protein 6
  • EGFL6
  • Egfl6
  • egfl6.S
  • LOC781765
Reaktivität
Human, Maus, Ratte (Rattus)
33
17
15
Wirt
Kaninchen
34
1
Klonalität
Polyklonal
Konjugat
Dieser EGFL6 Antikörper ist konjugiert mit Cy5
3
2
2
2
2
2
2
2
1
1
1
1
1
1
Applikation
Immunofluorescence (Paraffin-embedded Sections) (IF (p))
13
12
12
6
3
Optionen
Immunogen KLH conjugated synthetic peptide derived from human EGFL6
Isotyp IgG
Reinigung Purified by Protein A.
Plasmids, Primers & others Plasmide, Primers & weitere EGFL6 products on genomics-online (e.g. as negative or positive controls)
Antigen
Andere Bezeichnung Egfl6 (EGFL6 Antibody Abstract)
Hintergrund

This gene encodes a member of the epidermal growth factor(EGF) repeat superfamily. Members of this superfamily arecharacterized by the presence of EGF-like repeats and are ofteninvolved in the regulation of cell cycle, proliferation, anddevelopmental processes. The gene product contains a signalpeptide, suggesting that it is secreted, an EGF repeat regionconsisting of 4 complete EGF-like repeats and 1 partial EGF-likerepeat, 3 of which have a calcium-binding consensus sequence, anarg-gly-asp integrin association motif, and a MAM domain, which isbelieved to have an adhesive function. This gene is expressed earlyduring development, and its expression has been detected in lungand meningioma tumors. [provided by RefSeq, Jul 2008].

Synonyms: EGF like domain multiple 6, EGF repeat containing protein 6, EGF-like protein 6, EGF-like-domain multiple 6, egfl6, EGFL6_HUMAN, epidermal growth factor like protein 6, Epidermal growth factor-like protein 6, MAEG, MAM and EGF domain containing, MAM and EGF domains containing gene protein, MAM and EGF domains-containing gene protein, W80.

Gen-ID 25975
Applikations-hinweise IF(IHC-P) 1:50-200
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Konzentration 1 μg/μL
Buffer Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
Konservierungs-mittel Sodium azide
Vorsichtsmaßnahmen This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Lagerung 4 °C
Informationen zur Lagerung Store at 4°C
Haltbarkeit 12 months
Haben Sie etwas anderes gesucht?